Minerva Surgical, Inc. (UTRS): Price and Financial Metrics
UTRS Price/Volume Stats
| Current price | $0.00 | 52-week high | $14.00 |
| Prev. close | $0.41 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 100 |
| Day high | $0.00 | Avg. volume | 3,838 |
| 50-day MA | $0.63 | Dividend yield | N/A |
| 200-day MA | $2.60 | Market Cap | 8.88K |
UTRS Stock Price Chart Interactive Chart >
Minerva Surgical, Inc. (UTRS) Company Bio
Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Latest UTRS News From Around the Web
Below are the latest news stories about MINERVA SURGICAL INC that investors may wish to consider to help them evaluate UTRS as an investment opportunity.
ADBE Stock Alert: Adobe and Figma Terminate Merger AgreementAdobe stock is up on Monday as investors in ADBE react to the company calling off its merger plans with Figma due to regulatory reasons. |
Goldman Sachs Is Souring on Nokia (NOK) StockNokia stock is falling on Monday after shares of NOK were hit with a downgrade and lowered price target from Goldman Sachs. |
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?Minerva Surgical stock is falling hard on Monday after the women's healthcare company announced plans to delist UTRS shares. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning! |
Minerva Surgical Reports Third Quarter 2023 Financial ResultsSANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion produc |
UTRS Price Returns
| 1-mo | 0.00% |
| 3-mo | 0.00% |
| 6-mo | 0.00% |
| 1-year | 0.00% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 0.00% |
| 2023 | -73.81% |
| 2022 | -95.65% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...